Researchers report early results from therapy designed for a single patient with a rare genetic form of ALS

Mayo Clinic researchers report encouraging early results from an experimental therapy targeting the genetic cause of a rare ...
ALS News Today

MDA Engage: Patients can take steps to improve breathing issues

Noninvasive ventilation, cough-assist devices, and breathing exercises are among ways ALS patients can ease breathing issues. Early signs of weakening breathing function can be subtle. Patients should ...

Synthetic molecule improves mitochondrial function in ALS models and patient-derived stem cells

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease in which motor neurons are gradually lost, ...
Yahoo Finance

QurAlis Doses First Patient With ALS in Phase 1 Clinical Trial Evaluating QRL-101, a First-in-Class Kv7 Precision Therapy for ALS

CAMBRIDGE, Mass., Dec. 4, 2024 /PRNewswire/ -- QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the ...
STAT

ALS patient lived with a brain-computer interface for 7 years. Here’s what researchers learned

Rose covers disability and mental health, and she helps write STAT’s daily Morning Rounds newsletter. Confidential tips can be sent to Rose on Signal at rosebroderick.11. Brain-computer interfaces are ...
STAT

After Amylyx ALS trial failure, patients share disappointment and fear — but some hope

The news last week that a Phase 3 trial of Amylyx Pharmaceuticals’ amyotrophic lateral sclerosis drug — marketed as Relyvrio — failed to benefit patients compared to placebo hit the ALS patient ...
Medical Xpress

ALS drug testing in patient-derived cells provides personalized window into nervous system

Unlike other pathologies, amyotrophic lateral sclerosis (ALS) cannot be reproduced accurately in animal models, complicating the development of effective drugs. Faced with this challenge, a group of ...
Business Wire

Answer ALS Releases World's Largest ALS Patient-Based iPSC and Bio Data Repository

NEW ORLEANS--(BUSINESS WIRE)--In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest amyotrophic lateral sclerosis (ALS) ...
Science Daily

Experimental drug may benefit some patients with rare form of ALS

Some patients with a rare form of ALS benefited from an experimental therapy, with biomarker evidence of reduced injury to neurons and even limited functional recovery. When Columbia neurologist and ...

Aggie with ALS hoping to help raise awareness and funds for ALS research

In 1981, Chris Larkin suited up for Texas A&M football. More than four decades later, that same fighting spirit is helping ...
Fox News

Experimental ALS drug could offer new hope for patients if approved, researchers say

New hope could be on the horizon for ALS patients in the form of a "breakthrough" drug, researchers say. Neuvivo, a California biopharmaceutical company that develops therapies for neurodegenerative ...
EurekAlert!

Answer ALS releases world's largest ALS patient-based iPSC and bio data repository

Unprecedented resource, created with Cedars-Sinai, to accelerate ALS research and drive development of targeted therapies globally NEW ORLEANS, [November 14, 2024] — In a landmark continuing ...